PREVDUO

Peak

neostigmine methylsulfate and glycopyrrolate

R-Pharm US
NDAINTRAVENOUSSOLUTION
Approved
Feb 2023
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Oct 25, 2038
153 months away
Patent Expiry
Oct 25, 2038

Patent Records (5)

Patent #ExpiryTypeUse Code
10456354
Oct 25, 2038
Product
—
11110054
Oct 25, 2038
Product
—
11938217
Oct 25, 2038
Product
—
12151020
Oct 25, 2038
Product
—
12383491
Oct 25, 2038
Product
—
Company
R-Pharm US
R-Pharm US
NJ - Princeton
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers